GPI-15427 is a potent PARP-1 inhibitor capable of crossing the blood-brain barrier, which can significantly increased the antitumor activity of the methylating agent TMZ against malignant melanoma, glioblastoma multiforme, or lymphoma growing at the CNS site. GPI-15427 acts as a potent inhibitor of the enzyme, being capable of inhibiting the activity of purified PARP-1 at nanomolar concentrations. GPI-15427 induced significant sensitization to radiotherapy, representing a promising new treatment in the management of HNSCC.
Molecular Weight:
348.4
CAS Number:
[805242-85-7]
Formula:
C20H20N4O2
Target:
PARP|||Others
T68663
* VAT and and shipping costs not included. Errors and price changes excepted
